1. Determination of minimum bactericidal concentration, in single or combination drugs, against Mycobacterium tuberculosis
- Author
-
Aryadne Larissa de Almeida, Silvia Mt do Prado, Katiany Rizzieri Caleffi-Ferracioli, Giovana F Costacurta, Nathally Claudiane de Souza Santos, Rosilene Fressatti Cardoso, Andressa Lorena Ieque, Liliani Af da Silva, Regiane Bertin de Lima Scodro, Eloísa G Sampiron, Luciana Dias Ghiraldi Lopes, Rubia Af de Pádua, Vera Ld Siqueira, Dayane Cb Leal, and Daniela Ferrari Micheletti
- Subjects
Microbiology (medical) ,Minimum bactericidal concentration ,biology ,Isoniazid ,Broth microdilution ,Resazurin ,bacterial infections and mycoses ,biology.organism_classification ,Microbiology ,Mycobacterium tuberculosis ,chemistry.chemical_compound ,chemistry ,Levofloxacin ,Linezolid ,polycyclic compounds ,medicine ,bacteria ,Rifampicin ,medicine.drug - Abstract
Aim: To evaluate an assay to detect minimum bactericidal concentration (MBC) in Mycobacterium tuberculosis, using as single model rifampicin, isoniazid, levofloxacin (LVX) and linezolid (LNZ) and in combination. Material & methods: MBCs were carried out directly from resazurin microtiter assay plate and 3D checkerboard in M. tuberculosis H37Rv and five resistant clinical isolates. Results: The proposed MBC assay showed similar values to those determined by MGIT™, used as control. LVX and LNZ's MBC values were close to their MIC values. LNZ or LVX combined with isoniazid and rifampicin showed MBC value reduced in 63.7% of the assays. Conclusion: The proposed assay to determine MBCs of drugs can be applied to the study of new compounds with anti- M. tuberculosis activity to detect their bactericidal effect and also in laboratory routine for clinical dose adjustment of drugs according to the patient's profile.
- Published
- 2020
- Full Text
- View/download PDF